Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70
/in Hyperthermia, International Publications /von 2009-01-16 / Cell Death Differ. 2009 Apr;16(4):638-47Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line
/in Hyperthermia, International Publications /von 2009-01-15 / Cancer 2009 Jan;115(2):311-23Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches
/in Dendritic Cells, International Publications /von 2009-01-13 / Cancer Immunol. Immunother. 2009 Aug;58(8):1257-64Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-01-12 / J. Clin. Oncol. 2009 Feb;27(6):945-52Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death
/in Dendritic Cells, International Publications /von 2009-01-09 / Immunol. Lett. 2009 Jan;122(1):58-67Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications
/in Acute Leukemia, International Publications /von 2009-01-01 / Handb Exp Pharmacol 2009;(188):319-48Recent advances in cancer immunotherapy with an emphasis on vaccines
/in Colorectal Cancer, International Publications /von 2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):25-8Randomized clinical studies of anti-tumor vaccination: state of the art in 2008
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen /von 2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):51-66Tumour vaccine approaches for CNS malignancies: progress to date
/in Dendritic Cells, Glioblastoma, International Publications /von 2009-01-01 / Drugs 2009;69(3):241-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de